Mikkel Kristiansen

Mikkel Kristiansen is CEO of VentriJect, a Danish healthtech company spun out of Aalborg University that develops non-exercise methods for assessing cardiorespiratory fitness. VentriJect's technology combines seismocardiography with AI-driven analysis to estimate VO2max in under three minutes without exercise, and was a finalist at the 15th Healthcare Innovation World Cup. It is used today by healthcare providers across Europe and the US for health screening. Mikkel brings over a decade of international commercial leadership in regulated health-technology markets. Before VentriJect, he spent ten years at GN Group, a world-leading hearing-technology manufacturer, leading market entries across Europe and North America.